Nacov

Germany
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Community
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Adenovirus
  • Influenza-like illness/Acute respiratory infection
  • Diagnostics
  • Point of care tests

Winter COVID-19 Infection Study

United Kingdom
|
2023-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Community
  • SARS-CoV-2
  • Influenza-like illness/Acute respiratory infection

VIOOL

The Netherlands
|
2021-2023
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Community
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Adenovirus
  • Rhinovirus
  • Human metapneumovirus
  • Parainfluenza Virus
  • Enterovirus
  • Seasonal coronavirus
  • Bocavirus
  • Influenza-like illness/Acute respiratory infection

Vestesson

United Kingdom
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Primary care
  • Influenza-like illness/Acute respiratory infection
  • Pharmacological intervention
  • Telehealth

Shi

United Kingdom
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Community
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Influenza-like illness/Acute respiratory infection

RSV GOLD—ICU Network study

Bolivia Cameroon The Gambia Ghana Haiti Mozambique Nepal Nigeria Sudan Tanzania The Netherlands
|
2021-2023
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Emergency department
  • Respiratory syncytial virus
  • Influenza-like illness/Acute respiratory infection

RSV ComNet

Italy Spain The Netherlands Belgium United Kingdom
|
2021-2023
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Primary care
  • Respiratory syncytial virus
  • Influenza-like illness/Acute respiratory infection

RESPIRA-50

Italy
|
2023-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Primary care
  • Respiratory syncytial virus
  • Influenza-like illness/Acute respiratory infection

Racco

Italy
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Adenovirus
  • Rhinovirus
  • Human metapneumovirus
  • Parainfluenza Virus
  • Enterovirus
  • Bordetella pertussis
  • Seasonal coronavirus
  • Bordetella parapertussis
  • Chlamydia pneumoniae
  • Mycoplasma pneumoniae
  • Influenza-like illness/Acute respiratory infection
  • Diagnostics
  • Point of care tests

Pierantoni

Italy
|
2016-2024
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • Emergency department
  • Respiratory syncytial virus
  • Adenovirus
  • Rhinovirus
  • Human metapneumovirus
  • Parainfluenza Virus
  • Group A Streptococcus
  • Influenza A virus
  • Influenza B virus
  • Influenza-like illness/Acute respiratory infection
  • Diagnostics
  • Point of care tests

Bonora

Italy
|
2014-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Community
  • Influenza-like illness/Acute respiratory infection

Kodde

Germany Switzerland
|
2019-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • SARS-CoV-2
  • Influenza-like illness/Acute respiratory infection